Coronavirus antibodies last at least three months after infection, study suggests Oct 8, 2020 | Lunenfeld-Tanenbaum Research Institute Coronavirus antibodies can last at least three months after a person becomes infected with the virus that causes ...
Bridging the transition from hospital to home Sep 29, 2020 | Hennick Bridgepoint Hospital, Lunenfeld-Tanenbaum Research Institute, Sinai Health Dr. Carolyn Steele Gray (left) and Dr. Michelle Nelson (centre) are a scientists at Bridgepoint’s Collaboratory f...
Popular diabetes drug shown to improve health of mom and baby if taken during pregnancy Sep 15, 2020 | Lunenfeld-Tanenbaum Research Institute Women with Type 2 diabetes who take the blood glucose lowering drug metformin during pregnancy are more likely to...
Risk of COVID-19 infection highest for baby during early pregnancy, study finds Sep 3, 2020 | Lunenfeld-Tanenbaum Research Institute A developing baby may be most vulnerable for being infected with the virus that causes COVID-19 during early preg...
Sinai Health study looks at gene’s role in infertility, early menopause Aug 28, 2020 | Lunenfeld-Tanenbaum Research Institute Researchers are learning more about a little-known gene and the pivotal role it plays in female fertility and egg...
New research suggests popular diabetes medication not useful in reducing inflammation Jul 28, 2020 | Lunenfeld-Tanenbaum Research Institute New findings from Sinai Health reveal a class of drugs widely used to treat Type 2 diabetes don’t have much impac...